DK141098C - - Google Patents

Info

Publication number
DK141098C
DK141098C DK499275A DK499275A DK141098C DK 141098 C DK141098 C DK 141098C DK 499275 A DK499275 A DK 499275A DK 499275 A DK499275 A DK 499275A DK 141098 C DK141098 C DK 141098C
Authority
DK
Denmark
Application number
DK499275A
Other languages
Danish (da)
Other versions
DK499275A (fr
DK141098B (da
Inventor
C Cotrel
C Crisan
C Jeanmart
M N Messer
Original Assignee
Rhone-Poulenc Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7436963A external-priority patent/FR2313060A1/fr
Priority claimed from FR7527161A external-priority patent/FR2322601A1/fr
Priority claimed from FR7527160A external-priority patent/FR2322600A1/fr
Priority claimed from FR7527162A external-priority patent/FR2322602A1/fr
Application filed by Rhone-Poulenc Industries filed Critical Rhone-Poulenc Industries
Publication of DK499275A publication Critical patent/DK499275A/da
Publication of DK141098B publication Critical patent/DK141098B/da
Application granted granted Critical
Publication of DK141098C publication Critical patent/DK141098C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK499275AA 1974-11-07 1975-11-06 Analogifremgangsmåde til fremstilling af naphthyridinderivater. DK141098B (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
FR7436963 1974-11-07
FR7436963A FR2313060A1 (fr) 1974-11-07 1974-11-07 Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
FR7527161A FR2322601A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
FR7527160A FR2322600A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de la pyrrolo (3,4-b) pyrazine, leur preparation et les compositions qui les contiennent
FR7527160 1975-09-04
FR7527161 1975-09-04
FR7527162 1975-09-04
FR7527162A FR2322602A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de l'oxathiinno- et du dithiinnopyrrole, leur preparation et les compositions qui les contiennent

Publications (3)

Publication Number Publication Date
DK499275A DK499275A (fr) 1976-05-08
DK141098B DK141098B (da) 1980-01-14
DK141098C true DK141098C (fr) 1980-07-07

Family

ID=27446274

Family Applications (1)

Application Number Title Priority Date Filing Date
DK499275AA DK141098B (da) 1974-11-07 1975-11-06 Analogifremgangsmåde til fremstilling af naphthyridinderivater.

Country Status (27)

Country Link
US (1) US4220646A (fr)
JP (2) JPS5422996B2 (fr)
AR (2) AR208414A1 (fr)
AT (2) AT343123B (fr)
AU (1) AU503200B2 (fr)
BE (1) BE835325A (fr)
CA (1) CA1057755A (fr)
CH (1) CH609057A5 (fr)
CS (2) CS231957B2 (fr)
CY (1) CY1045A (fr)
DD (1) DD122684A5 (fr)
DE (1) DE2550111C2 (fr)
DK (1) DK141098B (fr)
FI (1) FI60707C (fr)
GB (1) GB1468497A (fr)
HK (1) HK19380A (fr)
HU (1) HU173108B (fr)
IE (1) IE41928B1 (fr)
IL (1) IL48423A (fr)
LU (1) LU73738A1 (fr)
NL (1) NL177405C (fr)
NO (1) NO143576C (fr)
OA (1) OA05162A (fr)
PL (1) PL101248B1 (fr)
SE (1) SE407063B (fr)
SU (2) SU673173A3 (fr)
YU (2) YU39583B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2371198A2 (fr) * 1976-11-22 1978-06-16 Rhone Poulenc Ind Nouveaux derives du dithiepinno (1,4)(2,3-c) pyrrole, leur preparation et les compositions qui les contiennent
US4533751A (en) * 1981-10-09 1985-08-06 Scm Corporation Preparation of 1,3-dienamines from myrcene and substituted myrcene
FR2525606A1 (fr) * 1982-04-22 1983-10-28 Rhone Poulenc Sante Nouveaux derives du dithiino (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent
FR2607506B1 (fr) * 1986-12-02 1989-01-06 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2671800B1 (fr) * 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.
US5786357A (en) * 1991-12-02 1998-07-28 Sepracor Inc. Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
HU214331B (hu) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5565567A (en) * 1993-06-04 1996-10-15 Henkel Corporation. Polymerizable N,N'-substituted piperazine acrylamide compounds
CA2164330A1 (fr) * 1993-06-04 1994-12-22 Paul E. Share Composes polymerisables
US5922820A (en) * 1993-06-04 1999-07-13 Henkel Corporation Polymerizable compounds
SK37997A3 (en) * 1994-09-23 1998-12-02 Arris Pharm Corp Compositions and methods for treating mast-cell inflammatory condition
US5663357A (en) * 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5756742A (en) * 1995-12-22 1998-05-26 Henkel Corporation Polymerizable compounds
US6339086B1 (en) 1999-05-14 2002-01-15 Swpracor, Inc. Methods of making and using N-desmethylzopiclone
EP1396493A4 (fr) * 2001-04-26 2005-08-03 Ajinomoto Kk Composes heterocycliques
DK1490363T3 (da) * 2002-03-29 2006-05-15 Indevus Pharmaceuticals Inc Fremgangsmåder til fremstilling af 2-7-chlor-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)1-isoindolinon
AU2003285012A1 (en) * 2002-10-24 2004-05-13 Sepracor, Inc. Compositions comprising zopiclone derivatives and methods of making and using the same
CN1326856C (zh) * 2002-11-22 2007-07-18 麦克公司 制备磷酸二酯酶－4抑制剂的方法
US6909002B2 (en) * 2002-11-22 2005-06-21 Merck & Co., Inc. Method of preparing inhibitors of phosphodiesterase-4
AR042194A1 (es) * 2002-11-22 2005-06-15 Merck & Co Inc Metodo para preparar inhibidores de fosfodiesterasa - 4
EP2343073A3 (fr) 2003-12-11 2011-10-12 Sepracor Inc. Combinaison de sédatif et modulateur neurotransmetteur et procédés d'amélioration de la qualité du sommeil et de traitement de la dépression
WO2005105061A2 (fr) * 2004-04-14 2005-11-10 Indevus Pharmaceuticals, Inc. Patch transdermique
WO2007005961A2 (fr) * 2005-07-06 2007-01-11 Sepracor Inc. Combinaisons d'un eszopiclone et d'un o-desmethylvenlafaxine, et methodes de traitement de la menopause et de l'humeur, de l'anxiete et des troubles cognitifs
MX2008000250A (es) 2005-07-06 2008-03-19 Sepracor Inc Combinaciones de eszopiclona y trans-4-(3,4-diclorofenil)-1,2,3,4- tetrahidro-n-metil-1-naftalenamina o trans 4-(3,4-diclorofenil)-1, 2,3,4-tetrahidro-1-naftalenamina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y
EP2258358A3 (fr) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenèse avec un inhibiteur de l'acetylcholinestérase
EP2275095A3 (fr) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenese par modulation des recepteurs muscariniques
CA2625153A1 (fr) 2005-10-21 2007-04-26 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
JP2009513672A (ja) 2005-10-31 2009-04-02 ブレインセルス，インコーポレイティド 神経発生のｇａｂａ受容体媒介調節
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651862A1 (fr) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenese induite par le recepteur 5ht
EP2021000A2 (fr) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenèse par modulation de l'angiotensine
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20080305171A1 (en) * 2007-06-07 2008-12-11 Kristin Anne Arnold Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there
CN100569775C (zh) * 2007-12-19 2009-12-16 齐鲁天和惠世制药有限公司 佐匹克隆的晶型转换的方法
CN102355892B (zh) 2009-01-30 2014-10-22 桑诺维恩药品公司 6-(5-氯-2-吡啶基)-5-[(4-甲基-1-哌嗪基)羰氧基]-7-氧代-6，7-二氢-5H-吡咯并[3，4-b]吡嗪的包衣片剂及测量包衣有效性的方法
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
JP6984656B2 (ja) * 2017-05-25 2021-12-22 信越化学工業株式会社 フルオロポリエーテル基含有ポリマー変性有機ケイ素化合物、表面処理剤及び物品
CN108129476A (zh) * 2017-11-27 2018-06-08 华中农业大学 一种杂环内酰胺衍生物及其用于作物病原菌杀菌剂的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1312427A (fr) * 1961-04-12 1962-12-21 Science Union Et Compagnie Soc Nouveaux dérivés de la pipérazine et leurs préparations
FR2101081B1 (fr) * 1970-08-19 1974-01-11 Rhone Poulenc Sa
BE790408A (fr) * 1971-10-22 1973-04-20 Rhone Poulenc Sa Nouveaux derives de la pyrrolo (3,4-b) pyridine, leur preparation et les compositions medicinales qui les
OA04285A (fr) * 1972-01-07 1979-12-31 Rhone Poulenc Sa Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
BE793851A (fr) * 1972-01-10 1973-07-10 Rhone Poulenc Sa Nouveaux derives de l'isoindoline, leur preparation et les compositions medicinales qui les contiennent
AR207555A1 (es) * 1972-12-04 1976-10-15 Procedimiento para preparar aril-6-piperazinocarboniloxi-5 oxo-7 tetrahidro-2,3,6,7 ditiino(1,4)(2,3-c)pirroles
OA04700A (fr) * 1973-05-15 1980-07-31 Rhone Poulenc Sa Nouveaux dérivés de la naphtyridine et leur procédé de préparation.

Also Published As

Publication number Publication date
AR208414A1 (es) 1976-12-27
FI60707B (fi) 1981-11-30
DE2550111C2 (de) 1983-09-15
AU503200B2 (en) 1979-08-30
HU173108B (hu) 1979-02-28
CA1057755A (fr) 1979-07-03
IE41928B1 (en) 1980-04-23
CS231958B2 (en) 1985-01-16
AR208800A1 (es) 1977-02-28
YU281575A (en) 1983-01-21
OA05162A (fr) 1981-01-31
YU192182A (en) 1983-01-21
IL48423A0 (en) 1976-01-30
HK19380A (en) 1980-04-18
NL177405C (nl) 1985-09-16
YU39583B (en) 1985-03-20
YU40087B (en) 1985-06-30
CY1045A (en) 1980-08-01
ATA848675A (de) 1977-09-15
JPS5170776A (fr) 1976-06-18
SE407063B (sv) 1979-03-12
NO143576C (no) 1981-03-11
SU673173A3 (ru) 1979-07-05
GB1468497A (en) 1977-03-30
SE7512477L (sv) 1976-05-10
FI60707C (fi) 1982-03-10
IE41928L (en) 1976-05-07
AT343123B (de) 1978-05-10
DK499275A (fr) 1976-05-08
CS751075A2 (en) 1984-01-16
NO143576B (no) 1980-12-01
CS231957B2 (en) 1985-01-16
JPS5422996B2 (fr) 1979-08-10
CS598377A2 (en) 1984-01-16
JPS5498790A (en) 1979-08-03
US4220646A (en) 1980-09-02
DK141098B (da) 1980-01-14
PL101248B1 (pl) 1978-12-30
AU8633175A (en) 1977-05-12
SU604496A3 (ru) 1978-04-25
JPS558508B2 (fr) 1980-03-04
BE835325A (fr) 1976-05-06
NO753713L (fr) 1976-05-10
NL7512732A (nl) 1976-05-11
DE2550111A1 (de) 1976-05-13
FI753127A (fr) 1976-05-08
NL177405B (nl) 1985-04-16
IL48423A (en) 1979-03-12
DD122684A5 (fr) 1976-10-20
AT343666B (de) 1978-06-12
ATA401977A (de) 1977-10-15
LU73738A1 (fr) 1976-09-06
CH609057A5 (fr) 1979-02-15

Similar Documents

Publication Publication Date Title
FR2289599B1 (fr)
FR2283535B1 (fr)
BR5408676U (fr)
AU479768A (fr)
AU480701A (fr)
AU482236A (fr)
BG19727A1 (fr)
BG19899A1 (fr)
BG20053A1 (fr)
BG20145A1 (fr)
BG20658A1 (fr)
BG20839A1 (fr)
BG20901A1 (fr)
BG21057A1 (fr)
BG21094A1 (fr)
BG21169A1 (fr)
BG21502A1 (fr)
BG21660A1 (fr)
BG21820A1 (fr)
BG22156A1 (fr)
BG22313A1 (fr)
BG22699A1 (fr)
BG23208A3 (fr)
BG26385A4 (fr)
BG26537A3 (fr)

Legal Events

Date Code Title Description
PBP Patent lapsed